Navigation Links
Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent

SUNDAY, June 5 (HealthDay News) -- Four of the most frequently prescribed epilepsy drugs appear to increase the risk of serious birth defects when taken early in pregnancy, a new study finds.

And the higher the dosage, the greater the risk, the international team of researchers reported in the June 6 online edition of The Lancet Neurology.

"Our results show that dose selection is as crucial as the choice of drug," the authors said in a journal news release. Their study gives doctors the opportunity to prescribe the safest anti-seizure medication at the safest level for women with epilepsy who want to get pregnant, they said.

The drugs studied were carbamazepine (Tegretol, Epitol), lamotrigine (Lamictal), valproic acid (Depakote), and phenobarbital.

The rate of birth defects was higher with increased dose for all the drugs, the researchers said, but they emphasized that the vast majority of women in their study delivered healthy children.

Most women with epilepsy need to take anti-seizure medication or risk harming themselves or their baby. Previous studies found that valproic acid, in particular, might increase the risk of birth defects, but those studies didn't look at individual doses. Nor did they take into account other influential factors, such as family history of birth defects or severity of epilepsy.

"Present guidelines caution on the use of valproic acid during pregnancy, but offer little guidance on alternative options and how to manage women whose seizures cannot be controlled by other drugs," Dr. Torbjorn Tomson, of the Karolinska Institute in Stockholm, Sweden, and colleagues, said in the news release.

For their 11-year study, the researchers used data from the International Registry of Antiepileptic Drugs and Pregnancy on nearly 4,000 pregnancies in 33 countries.

In all, 230 pregnancies resulted in major birth defects by the end of the first year after birth.

Low doses of lamotrigine (less than 300 milligrams [mg] per day) and carbamazepine (less than 400 mg per day) carried the smallest risk, the investigators found.

The greatest risk to the fetus was seen with the highest doses of valproic acid (1,500 mg a day or more) and phenobarbital (150 mg or more a day), the researchers said.

A family history of major birth defects quadrupled the risk, they found.

"The findings are important to the clinician treating people with epilepsy because they provide specific information not only on the drug but also on the dose," Dr. W. Allen Hauser, a professor of neurology and epidemiology at Columbia University in New York City, said in an accompanying editorial.

"It is easy to recommend against use of a specific drug (valproic acid, for instance) because of a higher risk of malformations, but if seizure control is not possible with alternative therapeutic regimens, such recommendations are difficult to implement," he continued.

"Incidence of major congenital malformations associated with a low dose of a higher-risk drug might be lower than that associated with a high dose of a lower-risk drug," Hauser added.

Commenting on the study, Dr. Jennifer Wu, an obstetrician/gynecologist with Lenox Hill Hospital in New York City, said: "This new study gives doctors and epileptic patients more information about safer drug choices. Patients with epilepsy should always try to plan their pregnancies. Some patients will be able to come off their medications, some patients will lower their dosages, and some patients will switch medications. This should all be done in the non-pregnant state."

More information

For more about epilepsy, visit the U.S. National Library of Medicine.

-- HealthDay Staff

SOURCES: June 6, 2011, The Lancet Neurology, online; Jennifer Wu, M.D., obstetrician/gynecologist, Lenox Hill Hospital, New York City

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Oldest Epilepsy Drug Best for Children
2. New study identifies best treatment for childhood epilepsy
3. Implant Shows Promise for Hard-to-Treat Epilepsy
4. Purple Day March 26th: The United States Goes Purple in Support of Epilepsy Awareness
5. Fetal alcohol spectrum disorder linked to high prevalence of epilepsy, Queens study
6. Gene Mutation Ups Risk of Sudden Death in People with Epilepsy
7. Children with epilepsy say their quality of life is better than their parents think
8. University Hospitals Neurological Institute hosts international epilepsy colloquium
9. Altered brain development found in children with newly diagnosed epilepsy
10. Children With Epilepsy Feel on Par With Healthy Siblings
11. Study confirms favorable long-term prognosis of epilepsy
Post Your Comments:
Related Image:
Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: